Author

Rick A. Finch

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adela M. Aldana· 1 shared Carolyn L. HodoiD· 1 shared Jake Jianjun WeniD· 1 shared Jianghua TuiD· 1 shared Julie Haewon RoweiD· 1 shared Kendra S. CarmoniD· 1 shared Li LiiD· 1 shared Ling WuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adela M. Aldana

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Anti-tumor activity of camptothecin analog conjugate of a RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer.

Yukimatsu Toh, Ling Wu, Jianghua Tu, Zhengdong Liang, Adela M. Aldana, Jake Jianjun Wen, Li Li, Sheng Pan, Julie Haewon Rowe, Martha E. Hensel, Carolyn L. Hodo, Rick A. Finch, Kendra S. Carmon, Qingyun J. Liu

This study develops and tests a camptothecin analog conjugate targeting LGR4/5/6 in CRC models, showing potent anti-tumor activity with minimal toxicity.

British Journal of Cancer · Aug 18, 2025Peer-reviewedPharmacology & Toxicology